InMode Return on Tangible Equity 2018-2025 | INMD
Current and historical return on tangible equity values for InMode (INMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| InMode Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $0.15B | $0.65B | 23.04% |
| 2025-06-30 | $0.18B | $0.63B | 26.97% |
| 2025-03-31 | $0.18B | $0.62B | 25.34% |
| 2024-12-31 | $0.18B | $0.70B | 24.48% |
| 2024-09-30 | $0.15B | $0.70B | 20.15% |
| 2024-06-30 | $0.15B | $0.75B | 19.51% |
| 2024-03-31 | $0.18B | $0.82B | 24.34% |
| 2023-12-31 | $0.20B | $0.79B | 28.64% |
| 2023-09-30 | $0.18B | $0.72B | 28.58% |
| 2023-06-30 | $0.18B | $0.67B | 31.56% |
| 2023-03-31 | $0.17B | $0.60B | 32.47% |
| 2022-12-31 | $0.16B | $0.56B | 33.77% |
| 2022-09-30 | $0.18B | $0.51B | 39.78% |
| 2022-06-30 | $0.17B | $0.45B | 41.79% |
| 2022-03-31 | $0.17B | $0.40B | 44.33% |
| 2021-12-31 | $0.17B | $0.42B | 46.60% |
| 2021-09-30 | $0.15B | $0.38B | 47.15% |
| 2021-06-30 | $0.13B | $0.33B | 46.04% |
| 2021-03-31 | $0.10B | $0.29B | 38.95% |
| 2020-12-31 | $0.08B | $0.26B | 33.82% |
| 2020-09-30 | $0.06B | $0.23B | 28.57% |
| 2020-06-30 | $0.05B | $0.21B | 27.03% |
| 2020-03-31 | $0.06B | $0.20B | 37.56% |
| 2019-12-31 | $0.06B | $0.18B | 52.25% |
| 2019-09-30 | $0.04B | $0.16B | 50.60% |
| 2019-06-30 | $0.04B | $0.07B | 81.40% |
| 2019-03-31 | $0.03B | $0.06B | 108.00% |
| 2018-12-31 | $0.02B | $0.05B | 204.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.953B | $0.395B |
| InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 24.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |